Literature DB >> 32488400

Cervical cancer screening abnormalities in immunosuppressed renal transplant women: case-control study in Southern Brazil.

Sibele Klitzke1, Isabella Osorio Wender2, Mila Pontremoli Salcedo1,3, Suzana Arenhart Pessini4,5.   

Abstract

PURPOSE: To evaluate the prevalence of cervical pre-malignancies in the cervical cytology of female renal transplant recipients (RTR) and compare to immunocompetent patients.
METHODS: A prospective case-control study of 165 RTR (cases) and 372 immunocompetent women (controls) was carried out from May 2015 to August 2016. The participants completed a questionnaire with demographic characteristics, habits, reproductive history, and information about the renal transplant. Cervical cytology samples were collected at their visit for cervical cancer screening. Relevant medical history was obtained from medical records and previous cervical cytology results were retrieved: from the time of kidney transplantation to the beginning of this study for RTR and all collected throughout life for controls.
RESULTS: The mean age was similar between groups (42.6 ± 11.4 vs. 41.8.2 ± 11.1 years, p = 0.447). Considering cervical cytology collected since the kidney transplant, RTR had three times higher rates of abnormal cervical cytology test (24.8% of RTR vs. 6.3% for controls), and the abnormalities were more frequent (p < 0.001) for low squamous intraepithelial lesion (LSIL) (n = 23, 13.9%) and high squamous intraepithelial lesion (HSIL) (n = 9, 5.5%). Cervical cytology collected during the study had normal results in 152 RTR (92.1%) vs. 326 controls (93.9%) (p > 0.05). When the altered results were broken down, a higher frequency of LSIL could be seen in RTR (3.6% vs 0.0%, p = 0.008).
CONCLUSION: RTR had significantly higher rates of cervical cytology abnormalities comparing to the control group and most of it was composed of LSIL.

Entities:  

Keywords:  Cervical cytology; Cervical intraepithelial neoplasia; Cervix uteri; Kidney transplantation

Mesh:

Year:  2020        PMID: 32488400     DOI: 10.1007/s00404-020-05621-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Human papilloma virus infection in female kidney transplant recipients.

Authors:  Shirin Ghazizadeh; Mahboob Lessan-Pezeshki; Mohamad Ali Nahayati
Journal:  Saudi J Kidney Dis Transpl       Date:  2011-05

Review 2.  Immunosuppression in kidney transplantation.

Authors:  Adriana Muntean; Mihai Lucan
Journal:  Clujul Med       Date:  2013-08-05
  2 in total
  3 in total

1.  Detection of HPV E6/E7 mRNA in the diagnosis of cervical cancer and precancerous lesions after kidney transplantation.

Authors:  Jing Sun; Yanna Yue; Rong Li; Qian Sun; Chaofeng Hu; Xiaohong Ge; Qingyan Guan
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Pregnancies and Gynecological Follow-Up after Solid Organ Transplantation: Experience of a Decade.

Authors:  Alice Bedin; Marie Carbonnel; Renaud Snanoudj; Antoine Roux; Sarah Vanlieferinghen; Claire Marchiori; Alexandre Hertig; Catherine Racowsky; Jean-Marc Ayoubi
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

3.  A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection.

Authors:  Aleksandra Wielgos; Bronisława Pietrzak; Barbara Suchonska; Mariusz Sikora; Lidia Rudnicka; Miroslaw Wielgos
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.